Anti-proliferative and pro-apoptotic effects of Uncaria tomentosa aqueous extract in squamous carcinoma cells

被引:26
作者
Ciani, Francesca [1 ]
Tafuri, Simona [1 ]
Troiano, Annaelena [2 ]
Cimmino, Alessi [3 ]
Fioretto, Bianca Saveria [2 ]
Guarino, Andrea Maria [2 ]
Pollice, Alessandra [2 ]
Vivo, Maria [2 ]
Evidente, Antonio [3 ]
Carotenuto, Domenico [4 ]
Calabro, Viola [2 ]
机构
[1] Univ Federico II, Dept Vet Med & Anim Prod, Via Veterinaria 1, I-80137 Naples, Italy
[2] Univ Federico II, Complesso Univ Monte S Angelo, Dept Biol, Via Cintia, I-80126 Naples, Italy
[3] Univ Federico II, Complesso Univ Monte S Angelo, Dept Chem Sci, Via Cintia, I-80126 Naples, Italy
[4] Univ Nacl Mayor San Marcos, Lima, Peru
关键词
Squamous carcinoma; Cat's claw; Y box binding protein 1; Oxidative stress; Cell death; NONMELANOMA SKIN-CANCER; DNA-REPAIR; CATS CLAW; YB-1; SURVIVAL; GROWTH;
D O I
10.1016/j.jep.2017.09.031
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Uncaria tomentosa (Willd.) DC. (Rubiacee), also known as una de gato, is a plant that grows wild in the upper Amazon region of Peru and has been widely used in folk medicine to treat several health conditions including cancer. We have produced an aqueous extract from Uncaria tomentosa (UT-ex) and analyzed its effects on squamous carcinoma cells and immortalized HaCaT keratinocytes. Squamous cell carcinoma (SCC) is an uncontrolled growth of abnormal cells arising in the skin's squamous layer of epidermis. When detected at an early stage, SCCs are almost curable, however, if left untreated, they can penetrate the underlying tissue and become disfiguring. We have evaluated cell proliferation, apoptosis and the level of reactive oxygen species following UT-ex treatment. UT-ex affected cell cycle progression and reduced cell viability in a dose and time-dependent manner. From a mechanistic point of view, this delay in cell growth coincided with the increase of reactive oxygen species (ROS). Furthermore, PARP1 cleavage was associated to the reduction of Y-box binding protein 1 (YB-1) 36 kDa, a nuclear prosurvival factor involved in DNA damage repair. These data indicate that UT-ex induced cell death can be ascribed, at least in part, to its ability both to induce oxidative DNA damage and antagonize the mechanism of DNA repair relying upon YB-1 activity. They also show that non metastatic SCCs are more susceptible to UT-ex treatment than untransformed keratinocytes supporting the use of UT-ex for the treatment of precancerous and early forms of squamous cell carcinomas. Preliminary chemical investigation of UT-ex revealed the presence of hydrophilic low-medium molecular weight metabolites with anticancer potential towards squamous carcinoma cells.
引用
收藏
页码:285 / 294
页数:10
相关论文
共 34 条
[1]  
Affolter C., 2000, STRUCTURE DETERMINAT, P161
[2]   An extract of Uncaria tomentosa inhibiting cell division and NF-κB activity without inducing cell death [J].
Åkesson, C ;
Lindgren, H ;
Pero, RW ;
Leanderson, T ;
Ivars, F .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2003, 3 (13-14) :1889-1900
[3]  
Alemasova EE, 2016, BBA-PROTEINS PROTEOM, V1864, P1631, DOI [10.1016/J.bbapap.2016.08.012, 10.1016/j.bbapap.2016.08.012]
[4]   Identification of ΔNp63α Protein Interactions by Mass Spectrometry [J].
Amoresana, Angela ;
Di Costanza, Antonella ;
Leo, Gabriella ;
Di Cunto, Ferdinando ;
La Mantia, Girolama ;
Guerrini, Luisa ;
Calabro, Viola .
JOURNAL OF PROTEOME RESEARCH, 2010, 9 (04) :2042-2048
[5]   Polypyrimidine tract-binding proteins are cleaved by caspase-3 during apoptosis [J].
Back, SH ;
Shin, SJ ;
Jang, SK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (30) :27200-27209
[6]   Non-melanoma skin cancer: what drives tumor development and progression? [J].
Boukamp, P .
CARCINOGENESIS, 2005, 26 (10) :1657-1667
[7]   Inhibition of p63 transcriptional activity by p14ARF:: Functional and physical link between human ARF tumor suppressor and a member of the p53 family [J].
Calabrò, V ;
Mansueto, G ;
Santoro, R ;
Gentilella, A ;
Pollice, A ;
Ghioni, P ;
Guerrini, L ;
La Mantia, G .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (19) :8529-8540
[8]  
Ccahuana-Vasquez R.A., 2007, BRAZ ORAL RES, V21
[9]   Proteasome inhibitors in cancer therapy [J].
Crawford, Lisa J. ;
Walker, Brian ;
Irvine, Alexandra E. .
JOURNAL OF CELL COMMUNICATION AND SIGNALING, 2011, 5 (02) :101-110
[10]  
De Oliveira L.Z., 2014, EVID-BASED COMPL ALT, V2014